#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13808	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2108	651.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1479	1479	C	803	C,T	744,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25128	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3544	707.0	0	.	n	.	0	T695C	SNP	695	695	T	982	982	C	750	C,T	697,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25128	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3544	707.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1624	1624	A	864	A	808	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25128	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3544	707.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2258	2258	C	779	C	719	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25128	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3544	707.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2884	2884	T	755	T	702	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25128	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3544	707.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2332	2332	A	823	A	761	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	V36A	NONSYN	106	108	GTG	482	484	GCG	170;171;175	G;C;G	157;157;161	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	524	526	CGG	187;187;187	C;G;G	171;171;170	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	S68L	NONSYN	202	204	TCG	578	580	TTG	177;175;177	T;T,C;G	152;159,1;161	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	A90V	NONSYN	268	270	GCG	644	646	GTT	163;163;165	G;T,C;T,G	151;144,1;145,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	I105V	NONSYN	313	315	ATT	689	691	GTT	159;158;156	G,A;T;T	152,1;147;148	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	N125T	NONSYN	373	375	AAT	749	751	ACC	167;168;169	A;C;C	148;151;153	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	R135C	NONSYN	403	405	CGT	779	781	TGT	174;174;173	T;G,A;T	157;162,1;157	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	K151E	NONSYN	451	453	AAA	827	829	GAA	154;152;153	G;A;A	140;140;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	830	832	AAC	151;148;149	A;A;C	140;137;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	A172T	NONSYN	514	516	GCG	890	892	ACA	133;133;131	A;C;A	128;127;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	A175E	NONSYN	523	525	GCG	899	901	GAA	132;130;131	G;A;A	124;122;122	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	E176T	NONSYN	526	528	GAA	902	904	ACC	134;135;135	A,G;C;C	118,1;123;123	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	I178V	NONSYN	532	534	ATC	908	910	GTC	135;135;135	G;T;C	121;122;121	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	I188T	NONSYN	562	564	ATA	938	940	ACG	148;149;149	A;C;G	131;134;134	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	P200N	NONSYN	598	600	CCC	974	976	AAC	149;148;147	A;A;C	144;141;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1034	1036	TTG	161;164;161	T;T;G	149;150;148	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1091	1093	ACC	153;152;155	A;C;C	137;138;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1094	1096	GAC	156;157;159	G;A;C,T,A	140;139;138,1,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1103	1105	GCG	157;156;158	G;C;G	137;122;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1139	1141	GCT	139;141;140	G;C;T	133;134;132	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1646	folP	858	858	91.61	folP.l15.c30.ctg.1	1505	108.9	1	SNP	p	R230S	1	.	.	688	690	AGC	1064	1066	AGC	172;172;172	A;G;C	158;159;159	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3483	157.1	1	SNP	p	S91F	0	.	.	271	273	TCC	554	556	TCC	194;192;193	T;C;C	177;175;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3483	157.1	1	SNP	p	D95G	0	.	.	283	285	GAC	566	568	GAC	192;189;188	G;A;C	179;176;177	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3483	157.1	1	SNP	p	D95N	0	.	.	283	285	GAC	566	568	GAC	192;189;188	G;A;C	179;176;177	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1568	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1242	125.6	1	SNP	p	G45D	1	.	.	133	135	GAC	455	457	GAC	210;210;210	G,A;A;C	193,1;195;197	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	826	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	966	85.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5036	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2871	174.6	1	SNP	p	D86N	0	.	.	256	258	GAC	531	533	GAC	182;184;187	G;A;C	171;173;177	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5036	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2871	174.6	1	SNP	p	S87W	0	.	.	259	261	AGT	534	536	AGT	190;190;192	A;G;T	177;178;180	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5036	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2871	174.6	1	SNP	p	S87R	0	.	.	259	261	AGT	534	536	AGT	190;190;192	A;G;T	177;178;180	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5036	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2871	174.6	1	SNP	p	S87I	0	.	.	259	261	AGT	534	536	AGT	190;190;192	A;G;T	177;178;180	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5036	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2871	174.6	1	SNP	p	S88P	0	.	.	262	264	TCC	537	539	TCC	191;192;193	T;C;C	179;179;182	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4390	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2560	170.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1480	1482	GGC	195;192;191	G;G;C	175;172;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1193	1195	GCA	189;189;188	G;C;A	177;175;179	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1196	1198	ATC	192;194;194	A;T;C	180;183;183	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1208	1210	GTG	203;201;201	G;T;G	190;189;186	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1208	1210	GTG	203;201;201	G;T;G	190;189;186	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1712	1714	ACC	183;179;178	A;C;C	163;164;163	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1766	1768	GCG	158;156;158	G;C;G	143;129;136	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1766	1768	GCG	158;156;158	G;C;G	143;129;136	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1889	1891	GGC	163;162;162	G;G;C	146;145;143	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1898	1900	GGC	158;158;156	G;G;C	140;140;141	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2309	163.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1916	1918	CCG	134;136;137	C,G;C,T;G,C	101,5;104,1;105,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5366	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3125	171.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1633	1635	CTG	196;195;193	C;T;G	176;173;175	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2264	porA	1146	1146	99.83	porA.l6.c17.ctg.1	1724	130.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	521	521	C	158	C	140	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	G38E	NONSYN	112	114	GGA	306	308	GAA	238;239;238	G;A;A	223;225;224	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	S46G	NONSYN	136	138	AGC	330	332	GGC	237;237;238	G;G;C	219;219;217	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	336	338	GGA	234;235;235	G;G;A	214;213;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	T87A	NONSYN	259	261	ACT	453	455	GCT	202;202;203	G;C;T	188;189;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	459	461	AGC	206;206;203	A;G,T;C	188;192,1;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	551	552	CG	218;217	C;G,T	203;200,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	554	556	CAG	215;215;217	C;A;G	201;201;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	558	560	AAA	216;215;216	A;A;A	202;202;204	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	621	623	GAA	201;204;206	G;A;A	189;190;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	645	647	GCA	224;228;229	G;C;A	208;211;214	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	A215T	NONSYN	643	645	GCT	837	839	ACT	178;178;181	A;C;T	165;164;166	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	I218M	NONSYN	652	654	ATA	846	848	ATG	183;182;182	A;T;G	172;170;169	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	T256A	NONSYN	766	768	ACA	960	962	GCA	196;194;197	G,T;C;A	187,1;185;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	W257T	NONSYN	769	771	TGG	963	965	ACG	198;197;199	A;C;G	189;187;188	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	S258G	NONSYN	772	774	AGT	966	968	GGG	200;199;196	G;G;G	190;189;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	A259V	NONSYN	775	777	GCT	969	971	GTT	196;194;197	G;T;T	186;183;187	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1029	1031	GTA	218;214;214	G;T;A	200;194;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1068	1070	ACT	222;224;226	A;C,G;T	208;209,1;214	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1074	1076	GAT	225;219;221	G;A;T	209;202;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1086	1088	CAC	230;228;227	C;A;C	216;215;215	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	1	SNP	p	G120K	1	.	.	358	360	AAG	551	553	CGG	218;217;214	C;G,T;G	203;200,1;198	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	1	SNP	p	A121D	1	.	.	361	363	GAC	554	557	CGC	215;217;219	C;G;C	201;205;205	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2622	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1383	187.2	1	SNP	p	D121N	0	.	.	361	363	GAC	554	557	CGC	215;217;219	C;G;C	201;205;205	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9460	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4805	196.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2047	2049	CAT	185;184;186	C,A;A;T	171,1;173;172	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1076	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1049	102.2	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	243;240;241	A;T;G	224;221;222	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
